Sort by
Refine Your Search
-
Listed
-
Country
-
Employer
- Umeå University
- Nature Careers
- University of Maryland, Baltimore
- University of Kentucky
- University of Minnesota
- Baylor College of Medicine
- Stanford University
- The Ohio State University
- Duke University
- FAPESP - São Paulo Research Foundation
- MOHAMMED VI POLYTECHNIC UNIVERSITY
- The University of Western Australia
- University of Oslo
- University of Utah
- VIB
- Delft University of Technology (TU Delft)
- EURECAT
- Heidelberg University
- Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
- Indiana University
- KU LEUVEN
- King's College London
- Leibniz
- Michigan State University
- Nencki Institute of Experimental Biology
- Okinawa Institute of Science and Technology Graduate University
- Rutgers University
- THE UNIVERSITY OF HONG KONG
- Technical University of Munich
- Texas A&M AgriLife
- Texas A&M University System
- The Swedish University of Agricultural Sciences (SLU)
- The University of Edinburgh;
- Umeå Plant Science Center
- Universite de Montpellier
- University of Lund
- University of Massachusetts Medical School
- University of Nebraska Medical Center
- University of Newcastle
- University of North Carolina at Chapel Hill
- University of Oxford
- University of Southern Denmark
- University of Texas at Arlington
- University of Texas at Tyler
- University of Washington
- Wageningen University & Research
- Zintellect
- 37 more »
- « less
-
Field
-
or equivalent degree Additional Information: Applicants must have a publication record that demonstrates research expertise in related fields. Candidates with prior experience in gene editing, gene therapy, and
-
signalling, cell biology, mouse neurobiology, CRISPR gene-editing or proteomics to investigate the function of the PINK1 kinase in neurons and the brain. The overarching goal of the Muqit lab is to undertake
-
related field). Strong research background in transcriptional regulation, cell biology, molecular biology, mouse models of cancer, and/or biochemistry. Prior experience in stem cells, Cas9/Crispr gene
-
generating and evaluating human or murine immune cells, gene editing, single cell transcriptomics, flow cytometry, and murine solid tumor models. Eligibility Applicants should be prospective postdocs or in
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | 3 months ago
. They will use bioinformatic and gene editing approaches to predict and functionally test hypotheses regarding the genetic underpinnings of Alzheimer’s Disease, leukemia, and osteoarthritis. We encourage
-
Responsibilities will include developing next-generation genome engineering technologies for gene and cell therapy applications as well as functional genomics. In particular, you will focus on delivery methods
-
using Cre-Lox and gene therapy approaches to editing of MP in vivo. The gene therapy approaches are in pre-clinical development as novel therapies for humans with hypertension and heart failure
-
the laboratory of Dr. Steven Fisher in the Division of Cardiology at the University of Maryland-Baltimore as of April 1, 2019. The federally funded project examines vascular smooth muscle gene expression and
-
pluripotent stem cells (hiPSCs). Primary responsibility is to utilize the CRISPR/Cas9 genomic engineering technology to examine the impact of genomic ablation of the candidate target genes on iPSC-CM and animal
-
the laboratory of Dr. Steven Fisher in the Division of Cardiology at the University of Maryland-Baltimore as of October 1, 2020. The federally funded project examines vascular smooth muscle gene expression and